Feature | October 15, 2014

Veterinarians can now treat tumors not historically treated with radiation

October 15, 2014 — Veterinary CyberKnife Cancer Center (VC3), a privately owned advanced radiation treatment center for veterinary use, today announced the opening of its facility in Malvern, Pa. The CyberKnife is a non-invasive way to deliver radiation to tumors, enabling treatment with greater precision than traditional linear accelerators and intensity modulated radiation therapy (IMRT) machines. The CyberKnife delivers an entire therapeutic dose of radiation in one to three treatments versus 17 to 20 treatments of traditional radiation therapy. VC3 has changed the way companion animals with cancerous tumors are treated.

CyberKnife (manufactured by Accuray Inc. of Sunnyvale, Calif.), is also called stereotactic radiosurgery. It utilizes a sophisticated robotic arm that revolves around the animal, delivering precisely targeted radiation to the tumor while sparing healthy tissue and surrounding organs. The precision of the CyberKnife allows tumors that haven’t historically been treated with radiation in the veterinary field, such as lung and liver tumors, to be treated. The end result is more precise and far fewer treatments, a significantly reduced number of anesthetic episodes, fewer visits to the veterinarian and a better quality of life for the pet and owner.

“The CyberKnife offers the best clinical option for the majority of my patients undergoing palliative or definitive radiation treatment,” said Siobhan Haney, DVM., M.S., DACVR (RO), MBA. Haney is a veterinary radiation oncologist at Hope Veterinary Specialists in Malvern, Pa.

VC3 owns and operates one of only two CyberKnifes in the world devoted for veterinary use and the only CyberKnife for veterinary use in the Mid-Atlantic region.

For more information: www.vetcyberknife.com

 


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now